Inorganic Chemistry Frontiers, Год журнала: 2025, Номер unknown
Опубликована: Янв. 1, 2025
An oxaliplatin( iv )-maleimide prodrug containing the STING agonist MSA-2 was synthesized with improved pharmacological properties and diminished hematotoxicity. The complex exerted anticancer effects but did not outperform free oxaliplatin or MSA-2.
Язык: Английский
Inorganic Chemistry Frontiers, Год журнала: 2025, Номер unknown
Опубликована: Янв. 1, 2025
An oxaliplatin( iv )-maleimide prodrug containing the STING agonist MSA-2 was synthesized with improved pharmacological properties and diminished hematotoxicity. The complex exerted anticancer effects but did not outperform free oxaliplatin or MSA-2.
Язык: Английский
Процитировано
0